Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Gains $5.6M in Private Debt, Stock Placement

NEW YORK (GenomeWeb News) — Tm Bioscience said yesterday that it has completed a private placement of unsecured subordinated debt and common share purchase warrants worth CA$6.24 million ($5.6 million)
The placement comes one day after the firm announced its second quarter financial results.  
Tm said it will use the proceeds to develop genetic tests and for general working capital purposes.
According to Tm, the debt carries an interest rate of 11 percent per year with monthly interest payments in arrears and principal to be repaid in full in 12 months or within 30 days in the event of any cash infusion that results in proceeds to Tm of $15 million.
Investors will receive 250 warrants per $1,000 principal amount of the debt purchased, Tm said. Each warrant will be exercisable for one common share of Tm’s stock at an exercise price of $1.15 per share for the next five years.
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.